Growth Metrics

ClearPoint Neuro (CLPT) Net Cash Flow (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 ClearPoint Neuro 375.84 Mn 340.24 Mn 7.76 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -221.64%
Dec 31, 2025 358.95%
Sep 30, 2025 -111.32%
Jun 30, 2025 480.12%
Mar 31, 2025 -425.32%
Dec 31, 2024 86.97%
Sep 30, 2024 -349.44%
Jun 30, 2024 -120.54%
Mar 31, 2024 1,116.06%
Dec 31, 2023 43.36%
Sep 30, 2023 -145.42%
Jun 30, 2023 180.23%
Mar 31, 2023 -165.40%
Dec 31, 2022 285.02%
Sep 30, 2022 81.59%
Jun 30, 2022 -487.15%
Mar 31, 2022 -25.66%
Dec 31, 2021 8.55%
Sep 30, 2021 -16.17%
Jun 30, 2021 -107.45%
Mar 31, 2021 723.68%
Dec 31, 2020 497.51%
Sep 30, 2020 -44.81%
Jun 30, 2020 -108.37%
Mar 31, 2020 2,192.63%
Dec 31, 2019 56.05%
Sep 30, 2019 -51.40%
Jun 30, 2019 -32.92%
Mar 31, 2019 0.06%
Dec 31, 2018 79.58%
Sep 30, 2018 -265.86%
Jun 30, 2018 54.04%
Mar 31, 2016 -111.47%
Dec 31, 2015 1,054.52%
Sep 30, 2015 42.85%
Jun 30, 2015 -4.02%
Mar 31, 2015 -112.84%
Dec 31, 2014 1,101.65%
Sep 30, 2014 -26.46%
Jun 30, 2014 -175.50%
Mar 31, 2014 250.82%
Dec 31, 2013 22.18%
Sep 30, 2013 12.33%
Jun 30, 2013 -129.30%
Mar 31, 2013 449.67%
Dec 31, 2012 -184.52%
Sep 30, 2012 658.75%
Jun 30, 2012 -129.87%
Mar 31, 2012 1,938.16%
Dec 31, 2011 114.30%
Sep 30, 2011 72.41%
Jun 30, 2011 -21.83%